Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.11.6925

PAMAM Dendrimers Augment Inhibitory Effects of Curcumin on Cancer Cell Proliferation: Possible Inhibition of Telomerase  

Mollazade, Mahdie (Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences)
Nejati-Koshki, Kazem (Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences)
Akbarzadeh, Abolfazl (Department of Medical Nanotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences)
Zarghami, Nosratollah (Tuberculosis and Lung Research Center, Tabriz University of Medical Sciences)
Nasiri, Marzieh (Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences)
Jahanban-Esfahlan, Rana (Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences)
Alibakhshi, Abbas (Department of Medical Biotechnology, Faculty of Advanced Medical Science, Tabriz University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.11, 2013 , pp. 6925-6928 More about this Journal
Abstract
Background: Despite numerous useful anticancer properties of curcumin, its utility is limited due to its hydrophobic structure. In this study, we investigated the comparative antiproliferative effect of PAMAM encapsulating curcumin with naked curcumin on the T47D breast cancer cell line. Materials and Methods: Cytotoxic effects of PAMAM dendrimers encapsulating curcumin and curcumin alone were investigated by MTT assay. After treating cells with different concentrations of both curcumin alone and curcumin encapsulated for 24h, telomerase activity was determined by TRAP assay. Results: While PAMAM dendrimers encapsulating curcumin had no cytotoxicity on cancer cells, they decreased the $IC_{50}$ for proliferation and also increased the inhibitory effect on telomerase activity. Conclusions: Considering the non-toxicity in addition to effectiveness for enhancing curcumin anticancer properties, dendrimers could be considered good therapeutic vehicles for this hydrophobic agent.
Keywords
Dendrimer; curcumin; telomerase; proliferation; breast cancer;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Adam Maciejczyk A (2013). New prognostic factors in breast cancer. Adv Clin Exp Med, 22, 5-15.
2 Alemdaroglu FE, Alemdaroglu NC, Langguth P, et al (2008). DNA block copolymer micelles- a combinatorial tool for cancer nanotechnology. Adv Mater, 20, 899-02.   DOI   ScienceOn
3 Araujo C, Leon L (2011). Biological activities of Curcuma longa L. Mem Inst Oswaldo Cruz, 96, 723-8.
4 Bengmark S, Mesa D, Gil A (2009). Plant-derived health- the effects of turmeric and curcuminoids. Nutr Hosp, 24, 273-81.
5 Bharali B, Khalil M, Gurbuz M, et al (2009). Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. Int J Nanomedicine, 4, 1-7.   DOI   ScienceOn
6 Bisht S, Feldmann G, Soni Sh, et al (2007). Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology, 5, 3.   DOI   ScienceOn
7 Cui SH, Qu X, Xie Y, et al (2006). Curcumin inhibits telomerase activity in human cancer cell lines. Int J Mol Med, 18, 227-31.
8 Gasparini G, Longo R, Torino F, Morabito A (2005). Therapy of breast cancer with molecular targeting agents. Ann Oncol, 16, 28-36.
9 Herbert B, Wright WE, Shay JW (2001). Telomerase and breast cancer. Breast Cancer Res, 3, 146-9.   DOI
10 Hsina I, Sheu G, Chen HL, et al (2010). N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells. Mutat Res, 688, 72-7.   DOI   ScienceOn
11 Jemal A, Bray FM, Center M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
12 Jurenka JS (2009). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Alt Med Rev, 14, 141-52.
13 Korkola J, Gray JW (2010). Breast cancer genomes - form and function. Curr Opin Genet Dev, 20, 4-14.   DOI   ScienceOn
14 Liu D, Hu H, Zhang J, et al (2011). Drug pH-sensitive release in vitro and targeting ability of polyamidoamine dendrimer complexes for tumor cells. Chem Pharm Bull, 59, 63-71.   DOI   ScienceOn
15 Morgan MT, Carnahan MA, Immoos SE, et al (2003). Dendritic molecular capsules for hydrophobic compounds. J Am Chem Soc, 125, 15485-9.   DOI   ScienceOn
16 Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, et al (2013). Inhibition of leptin and leptin receptor gene expression by silibinin- curcumin combination. Asian Pac J Cancer Prev, 14, [Epub Ahead of print].
17 Mukai H (2010). Targeted therapy in breast cancer: current status and future directions. Jpn J Clin Oncol, 40, 711-6.   DOI   ScienceOn
18 Nasiri M, Zarghami N, Nejati Koshki K, et al (2013). Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells. Asian Pac J Cancer Prev, 14, 3449-53.   DOI   ScienceOn
19 Nomani A, Haririan I, Rahimnia R, et al (2010). Physicochemical and biological properties of self-assembled antisense/poly (amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratio. Int J Nanomedicine, 5, 359-69.
20 Patil ML, Zhang M, Taratula O, et al (2009). Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting. Biomacromolecules, 10, 258-66.   DOI   ScienceOn
21 Ringman JM, Frautschy SA, Cole GM, et al (2005). A potential role of the curry spice curcumin in alzheimer disease. Curr Alzheimer Res, 2, 131-6.   DOI   ScienceOn
22 Shi W, Dolai S, Rizk S (2007). Synthesis of monofunctional curcumin derivatives, clicked curcumin dimer, and a PAMAM dendrimer curcumin conjugate for therapeutic applications. Org Lett, 9, 5461-4.   DOI   ScienceOn
23 Wang P, Zhao X, Wang Zh, et al (2010). Generation 4 polyamidoamine dendrimers is a novel candidate of nano-carrier for gene delivery agents in breast cancer treatment. Cancer Lett, 298, 34-49.   DOI   ScienceOn
24 Anand P, Thomas Sh, Kunnumakkara AB, et al (2008). Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol, 76, 1590-611.   DOI   ScienceOn
25 Winnicka K, Bielawski K, Bielawska A (2010). Synthesis and cytotoxic activity of G3 PAMAM-NH2 dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells. Pharmacol Rep, 62, 414-23.   DOI